ClinicalTrials.Veeva

Menu

Evaluation of a New Regional Organization to Promote Access to Renal Transplantation (TRACE)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Renal Failure

Treatments

Other: Regional organization for promotion of renal transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT03234075
69HCL17_0022

Details and patient eligibility

About

Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective treatment. Early and equitable access to transplantation is a public health issue. Access to transplantation is facilitated by early and systematic information and assessment of patients for inclusion in the national waiting list for transplantation prior to the onset of dialysis, and by the development of transplantation from living donors. In France, there are wide disparities in access to national waiting list registration and transplantation. One of the causes of these inequalities in access would be the disparity in referral practices to a transplant medical and surgical team authorized to register the individual on the national waiting list.

The aim of the TRACE study is to evaluate the impact of a new regional organization promoting renal transplantation on access to renal transplantation.

Enrollment

4,000 estimated patients

Sex

All

Ages

18 to 84 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient older than 18 years and younger than 85 years.
  • Entered in the French Network Epidemiology and Information in Nephrology register
  • Renal function supplementation begun in 2013 -- 2014 (period before regional organization implementation) or in 2018 -- 2019 (period after regional organization implementation).

Exclusion criteria

  • Patient followed in a Center of nephrology-dialysis or of Renal transplantation located outside French Auvergne Rhône Alpes or Center Regions.

Trial design

4,000 participants in 2 patient groups

Control group
Description:
Patients supported without regional organization for promotion of renal transplantation Setting : French Auvergne Rhone Alpes region and French Center region
Intervention group
Description:
Patients supported with the regional organization for promotion of renal transplantation Setting : French Auvergne Rhone Alpes region
Treatment:
Other: Regional organization for promotion of renal transplantation

Trial contacts and locations

1

Loading...

Central trial contact

Myriam PASTURAL-THAUNAT, Dr; Karine POYAU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems